Bcps
Impact in
- Internal Medicine top 1%
- Venous Thromboembolism Diagnosis and Management
-
- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Antiplatelet Therapy and Cardiovascular Diseases
- Acute Myocardial Infarction Research
Papers in
-
- Pharmaceutical Practices and Patient Outcomes 4
-
- Venous Thromboembolism Diagnosis and Management 4
- Co-authors
- Anna D. Garrett (3 shared papers)Jeffrey A. Bourret (2 shared papers)Erica Tavares (1 shared paper)Kate M. O’Dell (2 shared papers)Diana M Sobieraj (5 shared papers)Jennifer N. Clements (1 shared paper)Bradley M. Wright (5 shared papers)Joseph S. Bubalo (3 shared papers)
- Journals
- Journal of Oncology Practice (1 paper)The Psychiatric times (1 paper)
In The Last Decade
Bcps
33 papers receiving 1.0k citations
Bcps's Hit Papers
Peers
Comparison fields: 5 of 73
- Internal Medicine 445
- Cardiology and Cardiovascular Medicine 733
- Critical Care and Intensive Care Medicine 42
- Neurology 103
- Hematology 74
Countries citing papers authored by Bcps
This map shows the geographic impact of Bcps's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bcps with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bcps more than expected).
Fields of papers citing papers by Bcps
This network shows the impact of papers produced by Bcps. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bcps. The network helps show where Bcps may publish in the future.
Co-authors
The 23 scholars most cited alongside Bcps, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Idarucizumab for dabigatran reversal Hit paper breakdown → | 2015 | 999 |
| 2 | Treatment Patterns, Survival, and Healthcare Costs of Patients with Malignant Gliomas in a Large US Commercially Insured Population | 2014 | 29 |
| 3 | Treatment of rheumatoid arthritis: A review of recommendations and emerging therapy | 2011 | 7 |
| 4 | Fluorouracil Overdose: Clinical Manifestations and Comprehensive Management During and After Hospitalization | 2015 | 7 |
| 5 | Tofacitinib: A novel oral Janus kinase inhibitor for rheumatoid arthritis | 2012 | 4 |
| 6 | Palonosetron: A novel 5-HT3 receptor antagonist for chemotherapy-associated nausea and vomiting | 2003 | 3 |
| 7 | HER2 Receptor Antagonist–Associated Cardiotoxicity | 2016 | 3 |
| 8 | Monitoring Methotrexate Levels in a Patient After Glucarpidase Administration: A Case Report | 2020 | 3 |
| 9 | Evaluating the Effects of a 14-Day Oral Chemotherapy Dispensing Protocol on Adherence, Toxicity, and Cost | 2015 | 3 |
| 10 | Linaclotide: A guanylate cyclase type-C agonist for the treatment of constipation-predominant irritable bowel syndrome and chronic constipation | 2012 | 3 |
| 11 | Emotional Impact of Venous Thromboembolism: A Qualitative Study of Patients’ Journeys | 2017 | 3 |
| 12 | Adult ADHD: A Review of the Clinical Presentation, Challenges, and Treatment Options | 2015 | 2 |
| 13 | Blinatumomab: A Step Forward in the Treatment of B-Cell Precursor Acute Lymphoblastic Leukemia | 2019 | 2 |
| 14 | Dabigatran vs. warfarin in patients with mechanical heart valves | 2013 | 2 |
| 15 | Fingolimod: A potential first-in-class oral therapy for the treatment of relapsing-remitting multiple sclerosis | 2010 | 2 |
| 16 | Achieving Remission in Generalized Anxiety Disorder | 2009 | 2 |
| 17 | FDA approves first SGLT2 inhibitor for T2DM | 2013 | 2 |
| 18 | Spotlight on pharmaceutical pipeline database products : A useful resource for PBMs and MCOs | 2008 | 2 |
| 19 | Prescribing of Low-Molecular-Weight Heparin and Warfarin in Patients with Acute Venous Thromboembolism and Active Cancer | 2015 | 1 |
| 20 | Impact of Weight-Based Melphalan Dosing Strategies in Autologous Hematopoietic Stem-Cell Transplant for Multiple Myeloma | 2020 | 1 |
About Bcps
Bcps is a scholar working on Geriatrics and Gerontology, Internal Medicine, Cardiology and Cardiovascular Medicine, Genetics and Oncology, having authored 48 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pharmaceutical studies and practices (4 papers), Pharmaceutical Practices and Patient Outcomes (4 papers), Venous Thromboembolism Diagnosis and Management (4 papers), Atrial Fibrillation Management and Outcomes (4 papers), Cancer Treatment and Pharmacology (3 papers), Attention Deficit Hyperactivity Disorder (3 papers), Gastrointestinal motility and disorders (2 papers) and Economic and Financial Impacts of Cancer (2 papers). The work is most often cited by research in Internal Medicine (445 citations), Cardiology and Cardiovascular Medicine (733 citations), Critical Care and Intensive Care Medicine (42 citations), Neurology (103 citations) and Hematology (74 citations). Frequent co-authors include Anna D. Garrett, Jeffrey A. Bourret, Erica Tavares, Kate M. O’Dell, Diana M Sobieraj, Jennifer N. Clements, Bradley M. Wright, Joseph S. Bubalo, Margarita V. DiVall and Robert J. Cersosimo. Their work appears in journals such as Journal of Oncology Practice and The Psychiatric times.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.